Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cytarabine × CNS × Clear all

Phase

Phase 2 5 Phase 1/2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 144 Lymphoid 65 Myeloid 18 Classical hematology 6 Sarcoma 4 Plasma cell 4 Dermatologic 1 CNS 1 Breast 1

Conditions

Meningeal Carcinomatosis 1 Breast Neoplasms 1

Interventions

Radiotherapy 59 Temozolomide 53 Vincristine 29 Cyclophosphamide 28 Carboplatin 26 Radiosurgery 24 Cisplatin 23 Lomustine 22 Etoposide 21 Filgrastim 16 Magnetic Resonance Spectroscopy 15 Bevacizumab 13 Granulocyte Colony-Stimulating Factor 12 Doxorubicin 12 Radiation 11 Surgical Procedures, Operative 9 Procarbazine 9 Isotretinoin 9 Carmustine 9 Specimen Handling 8 Platinum 8 Peripheral Blood Stem Cell Transplantation 8 Chemotherapy, Adjuvant 8 etoposide phosphate 7 Melphalan 7 sargramostim 6 Topotecan 6 Radiotherapy, Intensity-Modulated 6 1,2-diaminocyclohexaneplatinum II citrate 6 Thiotepa 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645839 2019-06-12

DEPOSEIN

Centre Oscar Lambret

Phase 3 Completed

Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡